article thumbnail

Protein programmers get a helping hand from Cradle’s generative AI

TechCrunch

Interestingly the model itself is not biotech-specific exactly but a derivative of the same “large language models” that have produced text production engines like GPT-3. ” Generate Biomedicines raises $370M Series B with a focus on protein-based drugs. Image Credits: Cradle.

article thumbnail

Microsoft open sources EvoDiff, a novel protein-generating AI

TechCrunch

Proteins, the natural molecules that carry out key cellular functions within the body, are the building blocks of all diseases. Characterizing proteins can reveal the mechanisms of a disease, including ways to slow it or potentially reverse it, while creating proteins can lead to entirely new classes of drugs and therapeutics.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health And Biotech Startups Now Get The Majority Of US Series A Funding

Crunchbase News

This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.

Biotech 131
article thumbnail

TechCrunch+ roundup: Using predictive LTV, Boston VC survey, active learning for ML teams

TechCrunch

” Going private: A guide to PE tech acquisitions Biotech proved a surprisingly bright spot in 2022’s startup correction Image Credits: Getty Images The hard science and regulations that govern biotech companies sets them far apart from other startups. biotech deals also set new records in 2022 for both median deal size, $33.5

Biotech 212
article thumbnail

The 10 Biggest Rounds Of March: Wonder, Biotech Headline Big Month

Crunchbase News

Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.

Biotech 117
article thumbnail

TechCrunch+ roundup: 7 VCs who are taking pitches, AI best practices, zero-based budgeting

TechCrunch

Zero-based budgeting: A proven framework for extending runway 5 strategies for biotech startups to outlast a market downturn Image Credits: Getty Images Spinning up a biotech company is a massive undertaking. “The best founders look for a framework to strategically cut burn while keeping their startup’s value drivers functioning.”

Budget 230
article thumbnail

I’ve never seen so many crap startups

TechCrunch

We featured generative AI companies five years before the popular investors took notice and climate tech 2.0 Clean tech – Tied in with the biotech trend, we’re seeing a continued surge in input/output companies that process waste to produce byproducts like energy and potable water. It’s a big new data rush.

Biotech 221